Form 4 for NEO NEOGENOMICS INC
Accepted 2022-08-03 00:00:00 ET · period of report 2022-08-01 · accession 0001077183-22-000127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-03 | 2022-08-01 | NEO | Kulkarni Shashikant | Pres of Lab Ops | A - Grant | $0.00 | +24.7K | 65.9K | +60% | $0 |
| D | 2022-08-03 | 2022-08-01 | NEO | Kulkarni Shashikant | Pres of Lab Ops | A - Grant | $0.00 | +51.7K | 51.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-01 | A | A | 24,704 | $0.00 | 65,856 | D | — | — | (F1) On August 1, 2022, Dr. Kulkarni was granted 24,704 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-08-01 | A | A | 51,653 | $0.00 | 51,653 | D | $10.12 · — to 2029-08-01 | 51,653 Common Stock | (F3) On August 1, 2022, Dr. Kulkarni was granted 51,653 stock options. These options vest ratably over the first four anniversary dates of the grant date. |